|
Prescription Drug Search
Product Request Form
Dalfampridine is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Dalfampridine becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Dalfampridine:
- Albania
- Algeria
- Anguilla
- Argentina
- Aruba
- Azerbaijan
- Bahamas
- Bangladesh
- Belize
- Bermuda
- Bosnia and Herzegovina
- Brazil
- Cayman Islands
- Colombia
- Costa Rica
- Croatia
- Denmark
- Finland
- Grenada
- Guadeloupe
- Hong Kong
- Iceland
- India
- Italy
- Kuwait
- Lebanon
- Mauritius
- Morocco
- Nicaragua
- Peru
- Portugal
- Qatar
- Russian Federation
- Saudi Arabia
- Sri Lanka
- Switzerland
- Tonga
- United Kingdom, UK
- United States, US
- Uruguay
Latest news releases on Dalfampridine:
6 High-Growth Biotech Stocks Analysts Rate As Buys - Seekingalpha.com
Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.
6 High-Growth Biotechnology Stocks With Great Liquidity - Seekingalpha.com
Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.
Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013 - PharmiWeb
1AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg is developed and marketed in the U.S. by Acorda Therapeutics, Inc. and outside the U.S. by Biogen Idec, under a licensing agreement with Acorda Therapeutics, as FAMPYRA® (prolonged-release fampridine tablets).
